Chronic Inflammation and Hearing Loss: Key Biomarkers and Subgroup Differences by Gender and BMI in a National Cohort
- PMID: 40202507
- PMCID: PMC11980433
- DOI: 10.1002/iid3.70188
Chronic Inflammation and Hearing Loss: Key Biomarkers and Subgroup Differences by Gender and BMI in a National Cohort
Abstract
Background: Hearing loss (HL) significantly impacts quality of life and economic status worldwide. Chronic inflammation is suggested to influence hearing, yet the connection with inflammation-related indexes in the general population is not well understood.
Methods: This cross-sectional study analyzed data from 7231 adults from six cycles (2005-2012 and 2015-2018) of the National Health and Nutrition Examination Survey (NHANES). It examined the correlation between systemic immune-inflammatory biomarkers (NLR, SII, PLR, and LMR) and auditory threshold shifts/HL using multivariable logistic regression models. Smooth curve fitting visualized the association, and log-likelihood ratio tests determined the existence of thresholds in biomarker effects, supplemented by subgroup analyses.
Results: After adjustments, significant associations were found for low-frequency HL with ln-transformed NLR (OR = 1.29, 95% CI: 1.06-1.56, p = 0.0116), ln-SII (OR = 1.31, 95% CI: 1.08-1.59, p = 0.0065), and ln-LMR (OR = 0.74, 95% CI: 0.60-0.91, p = 0.00043). For high-frequency HL, similar patterns were observed for ln-SII (OR = 1.25, 95% CI: 1.05-1.48, p = 0.0105) and ln-LMR (OR = 0.76, 95% CI: 0.64-0.90, p = 0.007); however, the association with ln-NLR did not reach statistical significance (OR = 1.18, 95% CI: 1.00-1.40, p = 0.0562). NLR and SII positively correlated with HL, while LMR showed a negative correlation. No significant association was noted with PLR. Dose-response relationships were observed, particularly between LMR and all categorized frequencies of HL and between SII and high-frequency HL. Subgroup analyses indicated that NLR and SII are risk factors for HL in healthy BMI males, with LMR being more protective in males, the elderly, and diabetics.
Conclusions: Systemic inflammation-related indexes, especially SII, are predictive of both high- and low-frequency HL, highlighting the role of inflammatory homeostasis in hearing health. LMR may offer protective effects, particularly in specific subgroups. These findings suggest potential targets for HL treatment by regulating inflammation, warranting further investigation into their clinical application.
Keywords: NHANES; hearing loss; inflammatory biomarkers; population‐based study; systemic immune‐inflammation index.
© 2025 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals.Br J Dermatol. 2025 Jul 17;193(2):250-258. doi: 10.1093/bjd/ljaf147. Br J Dermatol. 2025. PMID: 40249082
-
The Association of Blood Cobalt Levels with Cardiovascular and Chronic Kidney Diseases: Mediating Role of Inflammatory Indicators (SII, NLR, PLR, NMLR, and LMR).Cardiovasc Toxicol. 2025 Aug;25(8):1149-1168. doi: 10.1007/s12012-025-10018-2. Epub 2025 Jun 18. Cardiovasc Toxicol. 2025. PMID: 40533700
-
Systemic immune-inflammation index and systemic inflammation response index levels are associated with coronary heart disease prevalence in the asthmatic population: a cross-sectional analysis of the NHANES 2011-2018.Front Public Health. 2025 Jul 8;13:1514016. doi: 10.3389/fpubh.2025.1514016. eCollection 2025. Front Public Health. 2025. PMID: 40697833 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
References
-
- Lin F. R., “Age‐Related Hearing Loss,” New England Journal of Medicine 390 (2024): 1505–1512. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources